Jaguar Health Inc
JAGX12.980USD
+1.110+9.35%
收盘 05/02, 16:00（美东）报价延迟15分钟
6.86M总市值
亏损市盈率 TTM
关于 Jaguar Health Inc 公司
Jaguar Health, Inc. 是一家商业阶段的制药公司。该公司专注于开发可持续地从雨林地区植物中提取的新型专利处方药，用于治疗患有胃肠道不适的人和动物。该公司通过两个部门运营：人类健康和动物健康。动物健康部门专注于开发和商业化伴侣动物和生产动物的处方和非处方产品。人类健康部门专注于开发和商业化人类产品以及持续商业化 Mytesi，Mytesi 用于缓解接受抗逆转录病毒治疗的人类免疫缺陷病毒 (HIV)/获得性免疫缺陷综合征 (AIDS) 成人患者的非感染性腹泻症状。Canalevia-CA1 用于治疗狗的化疗引起的腹泻 (CID)。其子公司 Napo Pharmaceuticals, Inc. 专注于开发和商业化人类处方药。
公司简介
公司代码JAGX
公司名称Jaguar Health Inc
上市日期May 13, 2015
成立日期2013
CEOMs. Lisa A. Conte
员工数量49
证券类型Ordinary Share
年结日May 13
公司地址200 Pine Street Suite 400
城市SAN FRANCISCO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编94104
电话14153718300
网址https://jaguar.health/
公司代码JAGX
上市日期May 13, 2015
成立日期2013
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Pravin R. Chaturvedi, Ph.D.
Dr. Pravin R. Chaturvedi, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
68.00
-65.83%
Mr. Jonathan S. Wolin
Mr. Jonathan S. Wolin
Chief of Staff, General Counsel, Chief Compliance Officer
Chief of Staff, General Counsel, Chief Compliance Officer
67.00
-66.33%
Mr. Jonathan B. Siegel
Mr. Jonathan B. Siegel
Independent Director
Independent Director
47.00
+4.60K%
Mr. John J. Micek, III
Mr. John J. Micek, III
Independent Director
Independent Director
--
--
Ms. Carol R. Lizak
Ms. Carol R. Lizak
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Steven R. King, Ph.D.
Dr. Steven R. King, Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
--
--
Dr. Anula K. Jayasuriya, M.D., Ph.D.
Dr. Anula K. Jayasuriya, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Ian Wendt
Mr. Ian Wendt
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Lisa A. Conte
Ms. Lisa A. Conte
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. James J. Bochnowski
Mr. James J. Bochnowski
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Pravin R. Chaturvedi, Ph.D.
Dr. Pravin R. Chaturvedi, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
68.00
-65.83%
Mr. Jonathan S. Wolin
Mr. Jonathan S. Wolin
Chief of Staff, General Counsel, Chief Compliance Officer
Chief of Staff, General Counsel, Chief Compliance Officer
67.00
-66.33%
Mr. Jonathan B. Siegel
Mr. Jonathan B. Siegel
Independent Director
Independent Director
47.00
+4.60K%
Mr. John J. Micek, III
Mr. John J. Micek, III
Independent Director
Independent Director
--
--
Ms. Carol R. Lizak
Ms. Carol R. Lizak
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Steven R. King, Ph.D.
Dr. Steven R. King, Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5 小时前
更新时间: 5 小时前
持股股东
股东类型
持股股东
股东统计
占比
Uptown Capital, LLC
7.54%
Iliad Research & Trading, L.P.
4.72%
Streeterville Capital LLC
2.08%
HRT Financial LP
0.19%
State Street Global Advisors (US)
0.09%
Other
85.38%
持股股东
股东统计
占比
Uptown Capital, LLC
7.54%
Iliad Research & Trading, L.P.
4.72%
Streeterville Capital LLC
2.08%
HRT Financial LP
0.19%
State Street Global Advisors (US)
0.09%
Other
85.38%
股东类型
股东统计
占比
Corporation
14.34%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.13%
Individual Investor
0.04%
Other
85.29%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
50
108.41K
14.71%
+24.74K
2024Q4
58
1.15M
16.97%
+379.12K
2024Q3
61
1.40M
25.15%
+578.82K
2024Q2
62
807.73K
26.56%
+336.48K
2024Q1
65
210.88K
23.56%
+139.83K
2023Q4
66
157.05K
30.73%
+119.23K
2023Q3
72
88.91K
41.12%
+74.12K
2023Q2
76
63.74K
33.22%
+52.52K
2023Q1
81
10.86K
23.83%
+3.44K
2022Q4
90
7.76K
30.63%
+877.00
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Uptown Capital, LLC
50.80K
7.78%
-804.00
-1.56%
Feb 18, 2025
Iliad Research & Trading, L.P.
31.83K
4.88%
+16.08K
+102.12%
Jul 18, 2024
Streeterville Capital LLC
14.00K
2.15%
+14.00K
--
Feb 18, 2025
HRT Financial LP
1.31K
0.2%
+1.31K
--
Dec 31, 2024
State Street Global Advisors (US)
605.00
0.09%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
3.87K
0.02%
+596.00
+18.21%
Dec 31, 2024
The Vanguard Group, Inc.
2.38K
0.01%
--
--
Dec 31, 2024
UBS Financial Services, Inc.
2.03K
0.01%
+676.00
+50.07%
Dec 31, 2024
Chaturvedi (Pravin R)
68.00
0.01%
-131.00
-65.83%
Feb 18, 2025
Wolin (Jonathan S)
67.00
0.01%
-132.00
-66.33%
Feb 18, 2025
查看更多
持股ETF
更新时间: 20 小时前
更新时间: 20 小时前
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
May 20, 2024
Merger
60<1
May 20, 2024
Merger
60<1
公告日期
类型
比率
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
Mar 18, 2025
Merger
25<1
May 20, 2024
Merger
60<1
May 20, 2024
Merger
60<1
May 20, 2024
Merger
60<1
May 20, 2024
Merger
60<1
Jan 20, 2023
Merger
75<1
Jan 20, 2023
Merger
75<1
查看更多